Question 1

How many shares of DCPH does Connor, Clark & Lunn Investment Management Ltd. own?

Accepted Answer

Connor, Clark & Lunn Investment Management Ltd. previously held 0 shares of DCPH (DECIPHERA PHARMACEUTICALS IN) before exiting the position in 2024-Q2.

Question 2

What is Connor, Clark & Lunn Investment Management Ltd.'s DCPH position worth?

Accepted Answer

Connor, Clark & Lunn Investment Management Ltd.'s DCPH position was last reported at $0 in 2024-Q2 before the exit.

Question 3

Is Connor, Clark & Lunn Investment Management Ltd. buying or selling DCPH?

Accepted Answer

In 2024-Q2, Connor, Clark & Lunn Investment Management Ltd. exited their DCPH position entirely (-100.0% change in shares).

Question 4

When did Connor, Clark & Lunn Investment Management Ltd. first buy DCPH?

Accepted Answer

Based on available 13F filings, Connor, Clark & Lunn Investment Management Ltd. first reported a position in DCPH in 2021-Q4. They have held the position across 9 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q1	Increased	279,047	+11.1%	$4.4M	0.0%	—	30
2023-Q4	Increased	251,145	+248.0%	$4.1M	0.0%	—	43
2023-Q3	Increased	72,172	+9.6%	$918,028	0.0%	—	27
2023-Q2	Increased	65,876	+314.6%	$927,534	0.0%	—	40
2023-Q1	New	15,887	-	$245,454	0.0%	—	32
2022-Q2	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q1	Increased	89,885	+142.1%	$833,000	0.0%	—	40
2021-Q4	New	37,128	-	$363,000	0.0%	—	33

DCPH9 quarters

DCPH
9 quarters